in India

Healthcare stocks rally over 2% as CLSA upgrades Dr Lal Pathlabs and Aurobindo; DRL drops on downgrade

150 Views

Healthcare stocks rallied on Thursday as Dr Lal Pathlabs and Aurobindo Pharma surged over 2% after CLSA upgraded their ratings to “outperform.” In contrast, Dr Reddy’s Laboratories dropped 1% following a downgrade to “underperform.”

The Nifty Healthcare Index advanced 0.6%, reflecting overall…

Read More

What do you think?

0 Points
Upvote Downvote

Written by pulseadmin

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

fmcg: Mid and smallcap stocks show signs of excessive valuations; fundamentals key to long-term recovery: Amnish Aggarwal

Stocks to buy in 2025: RIL, Paytm, KEI Industries among top 5 stocks that can offer 17-40% returns – Brokerage Recommendations